Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Current Liabilities (2018 - 2026)

TELA Bio has reported Total Current Liabilities over the past 8 years, most recently at $18.0 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 15.24% year-over-year to $18.0 million; the TTM value through Dec 2025 reached $18.0 million, up 15.24%, while the annual FY2025 figure was $18.0 million, 15.24% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $18.0 million at TELA Bio, up from $17.0 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $19.1 million in Q2 2025 and troughed at $5.6 million in Q1 2021.
  • A 5-year average of $13.9 million and a median of $15.1 million in 2024 define the central range for Total Current Liabilities.
  • Biggest five-year swings in Total Current Liabilities: surged 117.91% in 2022 and later dropped 8.07% in 2024.
  • Year by year, Total Current Liabilities stood at $10.6 million in 2021, then rose by 17.29% to $12.4 million in 2022, then surged by 36.8% to $17.0 million in 2023, then dropped by 8.07% to $15.6 million in 2024, then increased by 15.24% to $18.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for TELA at $18.0 million in Q4 2025, $17.0 million in Q3 2025, and $19.1 million in Q2 2025.